ReviewFrontiers in public health2026
Addressing implicit bias in pharmacy: strategies for equitable patient care and improved medication outcomes.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: As pharmacists' roles expand to include comprehensive clinical care, the quality of the pharmacist-patient relationship is increasingly critical to health outcomes. This narrative review examines the impact of implicit bias-the unconscious attitudes and stereotypes that influence perception and action on equitable pharmacy practice and synthesizes evidence-based strategies to mitigate its effects. Findings: A growing body of evidence confirms that implicit bias is a tangible factor in pharmacy practice, manifesting through disparities in communication, patient assessment, and clinical decision-making. While these biases are malleable through deliberate intervention, current research is limited by small-scale designs and a lack of pharmacy-specific measurement tools. Furthermore, the impact of bias-reduction on long-term clinical outcomes and the potential of emerging technologies, such as artificial intelligence, remain largely underexplored. Summary: This work presents a multi-level framework to address implicit bias in the pharmacy setting. At the individual level, strategies such as structured self-reflection (e.g., using the Implicit Association Test), perspective-taking, and mindfulness are essential to build practitioner awareness. At the organizational level, systemic changes such as standardizing care processes, fostering an inclusive environment, and implementing robust training programs are necessary to support individual efforts and ensure sustained improvement. Furthermore, integrating bias mitigation and cultural humility into pharmacy education curricula is fundamental in preparing the next generation of practitioners. Addressing implicit bias is not merely an ethical imperative but is, rather, a core component of high-quality, patient-centered care. A dedicated commitment to these strategies is crucial for advancing health equity and fulfilling the evolving role of the pharmacist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.